Home exercise program: Clinical Trials

3 trials of Home exercise program, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3

Follow Home exercise program: new trials by email Literature Review of Home exercise program trials Research Report on Home exercise program

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Starting a Testosterone and Exercise Program After Hip Injury
Testosterone, Placebo gel, Supervised exercise training - Hip Fracture, Frailty
Phase 3CompletedWashington University School of Medicine1292019-03-052025-02-04
Integrated Management of Pronation Deformity in Cerebral Palsy
Botulinum toxin type A, Upper extremity orthoses, Home exercise program - Cerebral Palsy
Phase 3CompletedKocaeli University352018-03-262020-04-16
Locomotor Experience Applied Post Stroke Trial
Early locomotor training program, Late locomotor training program, Home Exercise Program - Stroke
Phase 3CompletedDuke University4082006-04-012014-07-16

Conditions studied

Cerebral Palsy (1)  ·  Frailty (1)  ·  Hip Fractures (1)  ·  Motor Activity (1)  ·  Sarcopenia (1)  ·  Stroke (1)

Sponsors

Duke University (1)  ·  Kocaeli University (1)  ·  Washington University School of Medicine (1)

Countries

United States (2)  ·  Turkey (Türkiye) (1)

Top investigators

Andrea L. Behrman, Ph.D., PT (1)  ·  Bruce H. Dobkin, MD (1)  ·  Ellen F Binder, MD (1)  ·  Jay Magaziner, PhD (1)  ·  Katherine J. Sullivan, Ph.D., PT (1)  ·  Kenneth B Schechtman, PhD (1)  ·  Melike Akarsu, MSc (1)  ·  Pamela W. Duncan, PhD, PT, FAPTA, FAHA (1)  ·  Samuel S. Wu, Ph.D. (1)  ·  Stanley P. Azen, Ph.D., (1)  ·  Stephen E. Nadeau, MD (1)

Results publications

PMID 17996052, PMID 21612471, PMID 22246687, PMID 23504552, PMID 26498434, PMID 33481989, PMID 36070134, PMID 39113593, PMID 40372752, PMID 41624165

NIH funding

R01NS050506 (1)